N4 Pharma (LON:N4P) Stock Price Up 23.8% – What’s Next?
by Sarita Garza · The Markets DailyN4 Pharma Plc (LON:N4P – Get Free Report)’s stock price traded up 23.8% during trading on Wednesday . The stock traded as high as GBX 0.75 ($0.01) and last traded at GBX 0.65 ($0.01). 10,628,002 shares were traded during trading, an increase of 331% from the average session volume of 2,466,094 shares. The stock had previously closed at GBX 0.53 ($0.01).
N4 Pharma Stock Up 0.8 %
The company’s 50 day moving average price is GBX 0.62 and its 200 day moving average price is GBX 0.57. The company has a quick ratio of 7.28, a current ratio of 22.73 and a debt-to-equity ratio of 1.62. The firm has a market capitalization of £2.39 million, a price-to-earnings ratio of -55.00 and a beta of -0.37.
About N4 Pharma
N4 Pharma is a specialist pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines It has a unique silica nanoparticle delivery system called Nuvec® and another unique peptide.lipid system called Liptide® which it operates through its subsidiary Nanogenics Ltd
N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.
Recommended Stories
- Five stocks we like better than N4 Pharma
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Bank Stocks – Best Bank Stocks to Invest In
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year